Table 1.
Age | Gender | Race | Risk | Base line CD4 (%) | log HIV VL | log HCV VL | HCV Genotype | Outcome | |
---|---|---|---|---|---|---|---|---|---|
1 | 43 | Male | AA | MSM/SN | 980 (31) | 3.42 | 6.38 | 1B | Relapser |
2 | 42 | Male | C | MSM | 747 (30) | 1.69 | 6.82 | 1A | Relapser |
3 | 48 | Male | AA | SN | 1273 (51) | 1.69 | 6.86 | 1 | Relapser |
4 | 39 | Male | C | MSM/SN | 873 (35) | 1.69 | 6.68 | 1 | Relapser |
5 | 38 | Male | C | MSM/SN | 697 (38) | 1.69 | 7.35 | 1A | Relapser |
6 | 51 | Female | AA | SN | 512 (22) | 1.69 | 5.87 | 1 | Relapser |
7 | 62 | Male | C | MSM | 541 (28) | 2.69 | 6.26 | 1 | Relapser |
8 | 52 | Male | AA | MSM | 566 (16) | 3.74 | 5.81 | 1A | Relapser |
9 | 51 | Male | AA | MSM/SN | 710 (42) | 2.10 | 6.50 | 1A | Non responder |
10 | 44 | Female | AA | Heterosexual | 108 (6) | 1.69 | 6.55 | 1A | Non responder |
11 | 49 | Male | AA | SN | 392 (19) | 1.69 | 6.18 | 1B | Non responder |
12 | 48 | Male | C | SN | 610 (33) | 1.69 | 6.69 | 1 | Non responder |
13 | 49 | Male | AA | SN | 394 (22) | 1.69 | 6.66 | 1 | Non responder |
14 | 43 | Male | AA | MSM | 907 (31) | 1.69 | 5.92 | 1A | Non responder |
15 | 33 | Male | AA | MSM | 409 (22) | 1.69 | 6.72 | 1A | Non responder |
16 | 49 | Male | AA | SN | 516 (25) | 1.69 | 5.99 | 1 | Non responder |
17 | 35 | Male | C | MSM | 301 (20) | 2.84 | 6.30 | 1 | Non responder |
18 | 51 | Male | AA | SN | 301 (24) | 1.69 | 6.45 | 1 | Non responder |
19 | 42 | Male | C | MSM | 797 (27) | 3.76 | 6.89 | 1 | SVR |
20 | 48 | Male | AA | MSM | 553 (34) | 3.17 | 6.21 | 1A | SVR |
21 | 46 | Male | C | MSM | 519 (36) | 1.85 | 3.32 | 1A | SVR |
22 | 38 | Male | C | MSM/SN | 602 (31) | 4.52 | 6.40 | 1A | SVR |
23 | 48 | Male | C | MSM | 778 (33) | 1.69 | 5.80 | 1A | SVR |